Skip to main content
. 2019 Apr 1;2019(4):CD004149. doi: 10.1002/14651858.CD004149.pub3

Hosseini 2010.

Methods Design: single‐blind, randomised controlled trial
Comparison groups reported by study authors: CIMT vs conventional therapy
Country: Iran
Other: no protocol or trial registration identified
Groups defined by Cochrane authors
  • Intervention: mCIMT

  • Comparison: ow dose


Comparison defined by Cochrane authors and used in meta‐analysis: CIMT vs low dose
Participants Inclusion criteria
(a) Ability to extend wrist joint more than 20° and fingers in metacarpophalangeal joints at least 10° from full flexion
(b) More than 50% difference between involved and non‐involved hands in Jebson Taylor Test of Hand Function
(c) Ability to raise involved hand from surface of table more than 15 centimetres
(d) Score of at least 70 on Color Raven Test of IQ
(e) Willingness to participate in the research
Exclusion criteria
(a) Health difficulties not related to CP
(b) Treatment‐resistant seizures
(c) Visual problems that would interfere with carrying out the test
(d) Modified Ashworth Score average score greater than 3.5 in upper limbs
(e) Orthopaedic surgery on involved hand
(f) Rhizotomy in the last year
(g) Botulinum toxin treatment in muscles of upper limbs in the last six months or during the study
(h) Use of intrathecal baclofen in the six months before intervention or during the study
(i) Balance problems while wearing splint
Participants: 28 children with unilateral CP were recruited and allocated equally to groups
Randomisation method: “Participants have been selected based on stratified random sampling method. In this method, after providing sampling framework, persons based on inclusion and exclusion criteria have been classified in 4 levels, then samples has been selected randomly in two groups.” (p.51). No additional information was reported
Dropouts: intervention n = 2, comparison n = 1 (reasons were beginning of school season and length of sessions every day; reasons per group were not given)
Number of participants who received intended treatment: intervention n = 12, comparison n = 13
Number of participants who were analysed: total sample: n = 25; mean age = 7 years 5 months SD 5 years 4 months, range = not reported; 13 males, 12 females; 15 left hemiplegia, 10 right hemiplegia; MACS: not reported; GMFCS: not reported
Intervention group: n = 12; mean age = 7 years 10 months SD 7 years 6 months; 6 males, 6 females; 8 left hemiplegia, 4 right hemiplegia; MACS: not reported; GMFCS: not reported
Comparison group: n = 13; mean age = 7 years 10 months SD 1 years 5 months; 7 males, 6 females; 7 left hemiplegia, 6 right hemiplegia; MACS: not reported; GMFCS: not reported
Interventions Intervention Group (mCIMT)
Treatment dosage
Length: 10 days
Duration: 6 hours per day
Frequency: 10 days
Total dose of therapy time: face‐to‐face time with therapist = 60 hours
Description
Type of restraint device: splint
Hours per day restraint worn: not reported
Treatment environment: not reported
Individual or group: not reported
Therapy providers: not reported
Models of practice: not reported
Home programme: not reported
Comparison Group (low dose)
Treatment dosage
Length: unclear
Duration: unclear
Frequency: unclear
Total dose of therapy time: unclear
Description
Treatment environment: not reported
Individual or group: not reported
Therapy provider: not reported
Models of practice: NDT
Home programme: not reported
Outcomes Assessment time points: baseline; 2 weeks (Immediately postintervention)
Primary outcome measures
  • A primary outcome was not specified


No information on scoring/measurement units or direction and magnitude of scales were provided
Hand‐grip strength using handheld goniometer
Passive range of motion – muscle groups not specified
Modified Ashworth Scale – muscle groups not specified
Two‐point discrimination
Bruininks‐Oseretsky Test of Motor Proficiency – subscales used were: Manual Dexterity with non‐involved and involved hands separately, Bilateral Coordination, Upper‐Limb Coordination. Reason for exclusion: No established reliability or validity in CP
Jebsen Taylor Hand Function Test. Reason for exclusion: No established reliability or validity in CP
Active range of motion – muscle groups not specified. Reason for exclusion: No established reliability or validity in CP
Caregiver Functional Use Survey. Reason for exclusion: No established reliability or validity in CP
Unimanual function composite (for involved and uninvolved hands separately) – composite scores from Manual Dexterity and Jebsen Taylor Hand Function Test. Reason for exclusion: No established reliability or validity in CP
Bimanual Function composite – composite score from Bilateral Coordination, Upper‐Limb Coordination and Caregiver. Reason for exclusion: No established reliability or validity in CPFunctional Use Survey. Reason for exclusion: No established reliability or validity in CP
Notes Additional information sought from authors: letter emailed to corresponding author at: soortigi.ot@gmail.com on 22/7/2016 and reminder on 21/8/2016. No response from authors. No data available for inclusion in the review
Fundings sources: Pediatric Neurorehabilitation Center of University of Social Welfare and Rehabilitation Sciences
Study author declaration: no declaration given
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: Participants have been selected based on stratified random sampling method. In this method, after providing sampling framework, persons based on inclusion and exclusion criteria have been classified in 4 levels, then samples has been selected randomly in two groups”. Page 51
Comment:the authors do not report the nature of the strata nor any further details of the methods used to generate the allocation sequence. Insufficient information to permit judgement
Allocation concealment (selection bias) Unclear risk Quote: “Participants have been selected based on stratified random sampling method. In this method, after providing sampling framework, persons based on inclusion and exclusion criteria have been classified in 4 levels, then samples has been selected randomly in two groups.” Page 51
Quote: “Finally, randomly the participants were placed in constraint induced movement therapy and conventional therapy groups”.
Comment: not described. Insufficient information to permit judgement
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Quote: “This research has been performed with single blinded, randomized, control trial” page 51
Comment: blinding of participants and personnel was not possible
Blinding of outcome assessment (detection bias) 
 Self‐reported outcomes High risk Comment: blinding for self‐reported outcomes including CFUS was not possible
Blinding of outcome assessment (detection bias) 
 Objectively observed outcomes Unclear risk Quote: “This research has been performed with single blinded, randomized, control trial…” page 51
Comment: not described. Insufficient information to permit judgement
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Quote: “…due to beginning school season and being too long session in every day, 3 children failed (2 children in CIMT and 1 in conventional group).” Page 51
Comment: three of 28 children dropped out of intervention and therefore were not included in the analysis (89% completed). Reason for missing outcome data are unlikely to be related to true outcome and numbers were balanced across groups Completion of an intention‐to‐treat analysis was not specified
Selective reporting (reporting bias) High risk Comment: no study protocol located. Results for some of the measures specified in the paper were not reported